Clinical Trials · NCT04232969
Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- University College, London
- Enrollment
- 194
- Start date
- Jan 2020
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part 3